Mitsubishi UFJ Asset Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-135,382
| Closed | -$88.8K | – | 1643 |
|
|
2025
Q1 | $88.8K | Buy |
135,382
+11,345
| +9% | +$7.44K | ﹤0.01% | 1033 |
|
|
2024
Q4 | $161K | Buy |
+124,037
| New | +$161K | ﹤0.01% | 1022 |
|
|
2023
Q2 | – | Sell |
-76,068
| Closed | -$134K | – | 1143 |
|
|
2023
Q1 | $134K | Buy |
76,068
+6,458
| +9% | +$11.4K | ﹤0.01% | 1070 |
|
|
2022
Q4 | $219K | Buy |
69,610
+7,906
| +13% | +$24.8K | ﹤0.01% | 1012 |
|
|
2022
Q3 | $302K | Sell |
61,704
-1,170
| -2% | -$5.73K | ﹤0.01% | 976 |
|
|
2022
Q2 | $260K | Buy |
62,874
+29,131
| +86% | +$120K | ﹤0.01% | 1013 |
|
|
2022
Q1 | $196K | Buy |
33,743
+2,882
| +9% | +$16.7K | ﹤0.01% | 1061 |
|
|
2021
Q4 | $241K | Buy |
30,861
+1,980
| +7% | +$15.5K | ﹤0.01% | 1053 |
|
|
2021
Q3 | $260K | Buy |
28,881
+780
| +3% | +$7.02K | ﹤0.01% | 1026 |
|
|
2021
Q2 | $336K | Sell |
28,101
-6,285
| -18% | -$75.1K | ﹤0.01% | 1021 |
|
|
2021
Q1 | $431K | Buy |
34,386
+11,424
| +50% | +$143K | ﹤0.01% | 907 |
|
|
2020
Q4 | $358K | Buy |
22,962
+6,099
| +36% | +$95.1K | ﹤0.01% | 869 |
|
|
2020
Q3 | $159K | Sell |
16,863
-826
| -5% | -$7.79K | ﹤0.01% | 921 |
|
|
2020
Q2 | $158K | Sell |
17,689
-427
| -2% | -$3.81K | ﹤0.01% | 917 |
|
|
2020
Q1 | $115K | Buy |
18,116
+3,437
| +23% | +$21.8K | ﹤0.01% | 917 |
|
|
2019
Q4 | $121K | Buy |
14,679
+202
| +1% | +$1.67K | ﹤0.01% | 938 |
|
|
2019
Q3 | $131K | Buy |
14,477
+2,515
| +21% | +$22.8K | ﹤0.01% | 875 |
|
|
2019
Q2 | $129K | Sell |
11,962
-2,770
| -19% | -$29.9K | ﹤0.01% | 892 |
|
|
2019
Q1 | $141K | Buy |
14,732
+768
| +5% | +$7.35K | ﹤0.01% | 841 |
|
|
2018
Q4 | $154K | Buy |
13,964
+4,599
| +49% | +$50.7K | ﹤0.01% | 782 |
|
|
2018
Q3 | $159K | Buy |
+9,365
| New | +$159K | ﹤0.01% | 796 |
|